Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Haemonetics Corporation
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
Business
Feb 24 2025
Less than 1 min read

Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

news images

BOSTON, Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025 at 2:50 p.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj131/hae/1437678. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com 

David Trenk, Manager-Investor Relations      
(203) 733-4987
david.trenk@haemonetics.com

Media Contact:
Josh Gitelson, Sr. Director-Global Communications      
(781) 356-9776
josh.gitelson@haemonetics.com

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-46th-annual-institutional-investors-conference-302382632.html

SOURCE Haemonetics Corporation